Latest AI and machine learning research in other cancers for healthcare professionals.
Differentiating follicular thyroid adenoma (FTA) from carcinoma (FTC) remains challenging due to sim...
Bladder cancer is the fourth most common malignant tumor in men, with limited therapeutic biomarkers...
This paper explores how artificial intelligence (AI) is being woven into precision medicine for neur...
OBJECTIVES: Decades of clinical and fundamental research advancements in oncology have led to signif...
BACKGROUND: Ductal Carcinoma In Situ (DCIS) can progress to ipsilateral invasive breast cancer (IBC)...
BACKGROUND: Lymph node metastasis (LNM) is the most common route of metastasis in esophageal squamou...
Differentiating histologic subtypes of fat-poor small renal masses using conventional imaging remai...
Differentiation of adrenal incidentalomas (AIs) remains a challenge in the oncological setting. The...
Accurate predictions of T cell receptor (TCR) specificity remain an important open problem in immuno...
Over the past decade, liquid biopsy (LB) has emerged as a key tool in oncology. Its utility in non-i...
The intricate interplay between the gut microbiota and the GI tract has garnered significant attenti...
OBJECTIVES: This study aimed to develop and validate a machine learning (ML) model utilizing cerebro...
BACKGROUND: Hematogenous metastasis (HM) poses a significant challenge in the treatment and outcome ...
Pancreatic cancer is a highly aggressive malignancy with rising incidence and mortality rates, often...
Despite growing clinical use of contrast-enhanced ultrasound (CEUS), inconsistency remains in the mo...
The tumor microenvironment (TME) significantly influences cancer prognosis and therapeutic outcomes,...
OBJECTIVES: To study the characteristic factors associated with the occurrence of malignant nodules ...
BACKGROUND: The preoperative prediction of spread through air spaces (STAS) in patients with early-s...
BACKGROUND: Nervous system-cancer interactions can regulate tumorigenesis, invasion, and metastasis....
Checkpoint inhibitors (ICIs) are key therapies for NSCLC, but current selection criteria, such as e...
: Surgical pathology of tubo-ovarian and peritoneal cancer carries a well-recognised diagnostic work...